PHARMALY
ActiveSummary
PHARMALY has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16,019 and a net result of €13,519. Its solvency ranks better than 38% of 2,804 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
2025
16-12
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
05-02
Gazette deed
IncorporationAppointment: NIYONZIMA Lydia (director) · Founder · Founding capital8 facts ▸
Gazette deed
Incorporation
Appointment: NIYONZIMA Lydia (director) · Founder · Founding capital8 facts ▸
- Founder, NIYONZIMA Lydia (comparant)
- Incorporation, “PHARMALY” (deed in French)
- Founding capital, €2,500
- Capital
- Other provision, “décisions finales et transitoires, comparants” (deed in French)
- Registered office clause, “7000 Mons, Avenue de la Joyeuse Entrée 8” (deed in French)
- Director appointment, NIYONZIMA Lydia (director (not named in the articles))
- Pre-incorporation commitments, “takeover, engagements et obligations en résultant et activités entreprises au nom et pour compte de la société en formation” (deed in French)
Gazette deedNBB filing
1 of 1 deed read